Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Sionna Therapeutics Inc (SION)

Sionna Therapeutics Inc (SION)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences GlobeNewswire - Wed May 27, 7:00AM CDT

WALTHAM, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 37.30 (+1.55%)
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference GlobeNewswire - Wed May 13, 7:00AM CDT

WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 37.30 (+1.55%)
Sionna Therapeutics Reports First Quarter 2026 Financial Results GlobeNewswire - Tue May 12, 6:00AM CDT

Enrollment completed in the PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis; topline data on track...

SION : 37.30 (+1.55%)
Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis GlobeNewswire - Mon Apr 27, 6:00AM CDT

WALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 37.30 (+1.55%)
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium GlobeNewswire - Tue Apr 7, 6:00AM CDT

WALTHAM, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 37.30 (+1.55%)
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results GlobeNewswire - Mon Mar 2, 6:00AM CST

Ongoing PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis is on track with topline data anticipated...

SION : 37.30 (+1.55%)
Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences GlobeNewswire - Mon Feb 23, 7:00AM CST

WALTHAM, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 37.30 (+1.55%)
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 GlobeNewswire - Wed Feb 4, 6:00AM CST

WALTHAM, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 37.30 (+1.55%)
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire - Mon Jan 5, 6:00AM CST

WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 37.30 (+1.55%)
New York Stock Exchange NYSE in Manhattan by 4kclips via Shutterstock
Stocks Retreat as Bond Yields Rise Barchart - Mon Dec 1, 2025

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down by -0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.90%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.36%....

MSTR : 112.53 (-3.46%)
MPC : 242.91 (-0.69%)
GLXY : 34.20 (+3.51%)
LVS : 48.72 (+1.23%)
WYNN : 105.53 (+3.15%)
$IUXX : 30,406.19 (unch)
COIN : 163.26 (-1.00%)
ZNU26 : 109-105 (-0.27%)
SHOP : 108.85 (+0.70%)
SION : 37.30 (+1.55%)
ESU26 : 7,556.25s (-0.19%)
FANG : 183.50 (-1.07%)

Barchart Exclusives

Dear MicroStrategy Stock Fans, Mark Your Calendars for July 4 Barchart - Sat Jun 20, 11:00AM CDT
Strategy investors are closely watching the July 4 CLARITY Act deadline, which could reshape crypto regulation and influence bitcoin-linked stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.